Alexion's mission is to transform the lives of people living with rare diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. People living with rare and devastating diseases are our inspiration and our Guiding Star. We are driven because we know people's lives depend on our work.
In the UK, Alexion has therapies available for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), pediatric onset hypophosphatasia (HPP), and lysosomal acid lipase deficiency (LAL-D).
Transparency & Disclosure
Alexion is committed to operating with integrity, accountability, and transparency, and to complying with all applicable laws and regulations. Further information on disclosure can be found here.
Financial contributions to UK and Irish PAOs from 2015 – 2019
Financial contributions to UK and Irish PAOs can be found here.
Working at Alexion is an experience like no other. With a focus on rare diseases that have few, if any, effective treatments, each endeavor is urgent and every day counts. Groundbreaking innovation and life-saving therapies, driven by a team with a shared sense of purpose and dedication — that’s Alexion.